Analytical Evaluations
Click on the publication title to view the
full text (in pdf format).
In addition to our community-based research programs, our unit has also
conducted the following scientific evaluations on POCT devices for the
following tests:
Haemoglobin A1c (HbA1c)
Martin
D, Shephard M, Freeman H, Jones TW, Davis E and Maguire G. Point-of-care
testing of HbA1c and blood glucose in a remote Aboriginal Australian community.
Medical Journal of Australia 2005; 182: 524-527.
Shephard
M and Whiting M. Assessment of the practicability and analytical performance
of a point-of-care affinity chromatography haemoglobin A1c analyser for
use in the non-laboratory setting. Annals of Clinical Biochemistry 2006;
43; 513-515.
Lipids
Gialamas
A, Laurence C, Yelland L, Tideman P, Worley P, Shephard M et al. Assessing
agreement between point of care and laboratory results for lipid testing
from a clinical perspective. Clinical Biochemistry 2010; 43: 515-518.
Shephard
MDS, Mazzachi BC and Shephard AK. Comparative performance of two point-of-care
analysers for lipid testing. Clinical Laboratory 2007; 53: 561-566.
Shephard
MDS and Tallis G. Assessment of the point-of-care Cholestech Lipid Analyser
for lipid screening in Aboriginal communities. Australian Journal of Medical
Science 2002; 23: 4-10.
Urine Albumin:Creatinine Ratio
Shephard
MDS, Barratt L, Simpson-Lyttle W. Is the Bayer DCA 2000 acceptable as
a screening instrument for the early detection of renal disease? Annals
of Clinical Biochemistry 1999; 36: 393-394.
Creatinine
Shephard
MD, Peake MJ, Corso O, Shephard AK, Mazzachi BC, Spaeth BA, Mathew TH.
Assessment of the Nova StatSensor whole blood point-of-care creatinine
analyser for the measurement of kidney function in screening for chronic
kidney disease. Clinical Chemistry and Laboratory Medicine 2010; 48: 1113-1119.
Mazzachi
B, Lavender K and Shephard MDS. Improved performance of the blood creatinine
module on the i-STAT point-of-care analyser. Poster presented at the 39th
Annual Scientific Meeting of the Australasian Association of Clinical
Biochemists, Auckland, New Zealand (October 2001). Abstract published
in the Clinical Biochemists Reviews 2001; 22: 82.
Mazzachi
B, Lavender K and Shephard MDS. An assessment of the i-STAT point-of-care
analyser for biochemical monitoring of renal disease in remote areas.
Poster presented at the 38th Annual Scientific Meeting of the Australasian
Association of Clinical Biochemists (November 2000). Abstract published
in the Clinical Biochemist Reviews 2000; 21: 115.
The following landmark paper has also been
published concerning analytical goals for common POCT used for diabetes
management:
Shephard
M. Analytical goals for point-of-care testing used for diabetes management
in Australian health care settings outside the laboratory. Point-of-Care:
The Journal of Near-Patient Testing and Technology 2006; 5: 177-185.
Current POCT device evaluations undertaken
during 2008/9 which have not yet been published include studies of:
-
The Afinion analyser (Point of Care Diagnostics, Sydney)
for the measurement of Haemoglobin A1c
-
The Nova StatSensor (Nova Biomedical) for the measurement
of fingerprick whole blood creatinine.
